Akari Targets Mid-2027 for Human Trial of Differentiated Cancer Therapy
Akari Therapeutics reports positive preclinical data for AKTX-101 in urothelial cancer, showing efficacy in models resistant to current ADCs.
Read original at benzingaStocks · News reference
Why Amazon Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Amazon reported strong Q2 results, beating revenue and earnings estimates. Shares jumped 11.9% in pre-market trading while other stocks also saw gains/losses.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 31, 2026, 8:50 AM
- Checked
- Jul 31, 2026, 8:49 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Akari Therapeutics Announces Preclinical Data Of AKTX-101 Shows Anti-Tumor Activity Throughout Multiple Clinically Relevant Urothelial Cancer Preclinical Models
Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced new preclinical data demonstrating the
Read original at benzinga'Anthropic Considers Letting Shareholders Sell In IPO, Departing from SpaceX Playbook' - The Information
https://www.theinformation.com/articles/anthropic-considers-letting-shareholders-sell-ipo-departing-spacex-playbook
Read original at benzingaNvidia's Unusual Move Answers AI Trade’s Key Question; $40 Trillion US Debt Bomb Ticks; Key Fed Speech Awaited
Nvidia’s Unusual Move Please click here for an enlarged chart of NVIDIA Corp (NASDAQ:NVDA). Note the following: The chart shows that NVDA gapped up above the low band of Zone 1 (resistance). RSI on the
Read original at benzingaInside Amazon's Stock Drop: Why Analysts Remain High on AWS AI Momentum
Amazon stock fell nearly 2% despite bullish analyst forecasts predicting AWS revenue will top $335 billion behind surging AI cloud demand.
Read original at benzinga3 Artificial Intelligence (AI) Stocks Hedge Funds Are Buying Hand Over Fist
Major hedge funds including Peter Thiel's fund, David Tepper's Appaloosa Management, and others loaded up on Amazon, Alphabet, and Taiwan Semiconductor during Q2. Amazon's AWS grew 37% YoY, Alphabet's Google Cloud surged 82%, and TSMC benefits as the world's largest chip supplier for AI computing. All three stocks are positioned as strong AI investment opportunities.
Read original at the-motley-fool